Sanoma’s Interim Report 1 January – 30 June 2014:

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sanoma’s Interim Report 1 January – 30 June 2014: Strategy proceeding well – new media sales grew by 7%

Sanoma Corporation, Stock Exchange Release, 25 July 2014 at 8:30 CET+1

Second quarter

  • Net sales amounted to EUR 533.1 million (2013: 558.2).
  • Adjusted for changes in the Group structure, Sanoma’s net sales decreased by 1.0%.
  • Operating profit excluding non-recurring items was EUR 66.3 million (2013: 68.1).
  • Non-recurring items included in the operating profit amounted to EUR -63.0 million (2013: -27.3), mainly related to restructuring expenses as well as a capital loss and a write-down related to the sale of Belgian TV operations.
  • Earnings per share were EUR -0.13 (2013: 0.14).
  • Earnings per share excluding non-recurring items were EUR 0.23 (2013: 0.27).
  • Cash flow from operations was EUR -14.2 million (2013: -0.3).

First half

  • Net sales amounted to EUR 971.3 million (2013: 1,028.8).
  • Adjusted for changes in the Group structure, Sanoma’s net sales decreased by 3.5%.
  • Operating profit excluding non-recurring items was EUR 62.3 million (2013: 65.5).
  • Non-recurring items included in the operating profit amounted to EUR 103.0 million (2013: -64.5), mainly related to sales gains, restructuring expenses as well as a capital loss and a write-down related to the sale of Belgian TV operations.
  • Earnings per share were EUR 0.64 (2013: -0.10).
  • Earnings per share excluding non-recurring items were EUR 0.14 (2013: 0.23).
  • Cash flow from operations was EUR -66.3 million (2013: -65.9).

Change in reporting

Sanoma has adopted the new IFRS 11 Joint Arrangements as of 1 January 2014. The standard permits only the equity method in the consolidation of joint ventures, and the proportional consolidation method is no longer allowed. In the income statement the share of result in the joint ventures is presented as part of the operating profit and in the consolidated balance sheet as equity-accounted investees. The change primarily relates to Media Russia & CEE and Media Belgium.

Adoption of IFRS 11 reduced 2013 consolidated net sales by EUR 135.2 million. The impact on profitability is minor, 2013 operating profit excluding non-recurring items decreased by EUR 0.2 million. Balance sheet total on 31 December 2013 decreased by EUR 164.9 million and the total equity of the Sanoma Group reduced by EUR 59.1 million. Transition from the proportional consolidation method to the equity method also has impact on the cash flow statement.

As of 1 January 2014, Sanoma consists of two segments: Consumer Media and Learning. Sanoma reports net sales and profitability for three strategic business units: Media Netherlands, Media Finland and Learning. Media Belgium and Media Russia & CEE are reported in the category ‘Other’. Sanoma's financial reporting for 2013 has been adjusted to account for the changes.

Key indicators*

    Restated     Restated   Restated
  4–6/ 4–6/ Change 1–6/ 1–6/ Change 1–12/
EUR million 2014 2013 % 2014 2013 % 2013
Net sales 533.1 558.2 -4.5 971.3 1,028.8 -5.6 2,083.5
Operating profit excluding non-recurring items 66.3 68.1 -2.6 62.3 65.5 -4.9 154.6
  % of net sales 12.4 12.2   6.4 6.4   7.4
Operating profit 3.2 40.8 -92.0 165.3 1.0   -257.7
Result for the period -17.6 23.4   108.7 -27.9   -320.3
               
Capital expenditure ** 13.3 21.4 -37.9 22.9 32.8 -30.1 65.6
  % of net sales 2.5 3.8   2.4 3.2   3.1
               
Return on equity (ROE), % *** -14.9 n.a.   -24.2
Return on investment (ROI), % *** -3.7 n.a.   -9.2
Equity ratio, %       40.3 38.1   37.2
Net gearing, %       76.6 102.5   95.7
               
Number of employees at the end of the period (FTE) 8,721 9,524 -8.4 9,035
Average number of employees (FTE) 8,745 9,696 -9.8 9,446
               
Earnings/share, EUR -0.13 0.14   0.64 -0.10   -1.89
Cash flow from operations/share, EUR -0.09 0.00   -0.41 -0.40   0.73
Equity/share, EUR       5.79 6.61 -12.5 5.42

* Comparable figures have been restated due to a new IFRS11 ‘Joint Arrangements’.
** Including finance leases.
*** Rolling 12-month period.

Harri-Pekka Kaukonen, President and CEO

“During the second quarter we took a number of good steps in implementing our transformation strategy. Our year-on-year organic growth improved from -6% in the first quarter to -1% in the second quarter and our new media sales (non-print sales) grew by 7%. In the second quarter, more than 42% of our consumer media sales in the Netherlands and Finland were generated from non-print products and services. We continued to streamline our portfolio and divested several non-core assets.

The market conditions in the Finnish consumer media are still challenging, but our profitability ended up close to last year’s level due to cost savings. Online- TV and pay-TV showed particularly robust growth. In addition, radio operations performed very well, with market share gains supported by good growth in the radio advertising market.

In the Netherlands, our consumer media operations experienced a good quarter supported by improvement in consumer confidence and advertising market. This year our SBS TV operation has improved its viewing share month after month, excluding international sports events. In May, the viewing share was at its highest level in almost three years. Naturally the FIFA World Cup had a huge negative but temporary impact on viewing shares for all commercial TV operators. Overall profitability in the Netherlands in the second quarter was below last year’s level due to a lower result in the print business.

The learning business has, by nature, an annual cycle and strong seasonality. The seasonally strong second quarter saw solid performance supported by timing shifts from the first and the third quarters.

The cost savings programme is proceeding well. We have now passed the half way mark, with the annual run-rate being just above EUR 50 million at the end of June. Our focus is turning more and more towards growth, as multiple measures regarding cost savings and divestments have already been carried out.”

Group outlook (unchanged)

In 2014, Sanoma expects that the Group’s consolidated net sales adjusted for structural changes will decline somewhat compared to 2013. The operating profit margin excluding non-recurring items is estimated to be below the previous year’s level (2013: 7.4% of net sales).

Sanoma’s outlook is based on three major factors: 
(1) continued negative pressure on sales and operating profit due to declining print markets and weak economic development in Sanoma’s core operating countries,
(2) strong positive impact from the EUR 100 million cost savings programme, and
(3) increased investment levels to fund digital transformation and growth in Consumer Media and the expansion into tutoring and emerging markets in Learning.

Mid-term outlook (unchanged)

Based on the execution of the strategic redesign, Sanoma expects that from 2016 onwards, the Group’s consolidated net sales will return to organic growth. The operating profit margin excluding non-recurring items is targeted to be around 10% of net sales. Sanoma is targeting for a net debt to EBITDA ratio below 3.5.

January-June 2014 Interim Report webcast

The event for analysts and investors will be held in English by President and CEO Harri-Pekka Kaukonen and CFO Kim Ignatius at 11:00 Finnish time (9:00 UK time) at Nelonen studio, Sanomatalo, Töölönlahdenkatu 2, Helsinki. The live webcast can be viewed on Sanoma’s website at www.sanoma.com/en/investors and on demand after the event.

Please join by dialing
Finland: +358 (0)9 2313 9201 / Netherlands: +31 (0)20 7965 008 / UK: +44 (0)20 7162 0077 / US: +1 334 323 6201
Conference id: 944899

Financial reporting 2014

Sanoma will publish its Interim Report January-September on 29 October 2014, at approx. 8:30. a.m. Finnish time


Additional information
Sanoma's Investor Relations, Olli Turunen, tel. +358 40 552 8907 or ir@sanoma.com

Sanoma.com

Get the world. Sanoma helps people access and understand the world.

We believe in a world full of opportunities, feelings, reactions and inspiration. A world that you can reach, influence, explore and share. We want to make it yours.

Sanoma is a front running consumer media and learning company in Europe. In Finland and the Netherlands we are the market leading media company with a broad presence across multiple platforms. Our main markets in learning are Belgium, Finland, the   Netherlands, Poland and Sweden. In 2013, Sanoma’s net sales totalled EUR 2.1 billion. Sanoma is listed on the NASDAQ OMX Helsinki stock exchange.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 307

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 211

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 246

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 694

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 351

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 239

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 27

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 180

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

HD Hyundai Sparks Fusion Hopes with ITER Milestone

Updated Category News Views 9

Hold on to Your Hard Hats, Fusion Milestone Achieved Look who's making waves in the world of nuclear fusion. HD Hyundai Heavy Industries has hit a crucial benchmark in the ITER nuclear fusion project. This ain't your run-of-the-mill accomplishment, folks. We're talking about completing the assembly of some of the most complex and intricately designed machinery known to...

Continue Reading
ChemoMetec Boosts Financial Outlook with Anticipated Growth

Updated Category News Views 353

ChemoMetec Boosts Financial Outlook Amid Growing Interest ChemoMetec is excited to announce an upgrade in its financial guidance as the company sees a growing demand for its pioneering technologies, particularly the highly regarded XcytoMatic platform. This surge in interest bodes well for the company's revenue and profit, reflecting a positive trajectory as it approaches...

Continue Reading
GDS Holdings Completes Successful C-REIT IPO on Shanghai Exchange

Updated Category News Views 200

GDS Holdings Limited Celebrates C-REIT IPO Success GDS Holdings Limited, known as GDS, is thrilled to announce that it has successfully completed its initial public offering of its China REIT, or C-REIT, on the Shanghai Stock Exchange. This milestone marks an exciting moment for the company and its stakeholders as market interest surpassed expectations. Highlighting the...

Continue Reading
Innovative E-Waste Solutions from Techbros Redefine Recycling

Updated Category News Views 273

AI-Driven E-Waste Innovation from Techbros In a remarkable leap towards sustainability and innovative technology, Techbros Electronic Recycling proudly announces the launch of the Southwest's first fully integrated AI-driven IT asset disposition (ITAD) and e-waste processing facility. This state-of-the-art facility exemplifies the future of electronics recycling by...

Continue Reading
SageSure Welcomes Insurance Veteran Peter Hearn to Board

Updated Category News Views 268

SageSure Welcomes New Board Member SageSure, one of the largest managing general underwriters that focus on markets exposed to catastrophe risks, has taken a significant step by appointing Peter Hearn to its Board of Managers. This strategic move is anticipated to bolster the company’s leadership and industry insights. Peter Hearn's Impressive Background Peter Hearn...

Continue Reading